The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off


Objective: The hepatoprotective action of Amukkarac curanam (AC), a widely used Siddha medicine was evaluated using acetaminophen-induced hepatic damage in rats. Material and methods: AC was administered orally at a dose of 500 mg/kg body weight for 7 days. Serum levels of transaminase (AST, ALT), alkaline phosphate (ALP), bilirubin, Total protein (TP) and albumin (Alb) were used as the biochemical markers of hepatotoxicity. Liver thiobarbituric acid reactive substances and histopathological studies were also done to confirm the biochemical changes. Results and Discussion: The results of the study indicate that pretreatment with AC significantly reversed the increased levels of serum marker enzymes such as AST, ALT, ALP and bilirubin, when compared to acetaminophen-induced group. The level of liver thiobarbituric acid reactive substances was also brought to near normal. AC has protected the liver from acetaminophen-induced damage. Probable mechanism of action is by protection against oxidative damage produced by acetaminophen.

Keywords

Acetaminophen, Amukkarac Curanam, Marker Enzymes, Thiobarbituric Acid Reactive Substances, Histopathological Studies
Font Size

User

Notifications
JOURNAL COVERS